Open Orphan (ORPH.L): Contract extension with major pharma client | Destiny Pharma (DEST.L): Update on clinical programme for the prevention of C. difficile infection
22 Dec 2020
SP Angel Healthcare Conditions- 22-12-2020
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions- 22-12-2020
hVIVO plc (HVO:LON), 26.5 | Destiny Pharma Plc (DEST:LON), 21.2
- Published:
22 Dec 2020 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
2
Open Orphan (ORPH.L): Contract extension with major pharma client | Destiny Pharma (DEST.L): Update on clinical programme for the prevention of C. difficile infection